Overview

• GY-NA•TREN is your reliable and dependable choice for vaginal health. GY-NA•TREN is the only dual-action kit (Oral Probiotic Supplement and Vaginal Homeopathic Treatment with a National Drug Code) available today.

Description

GY-NA•TREN^®
Easy to use dual-action system for restoring and maintaining optimal feminine health.

GY-NA•TREN is your reliable and dependable choice for vaginal health.  GY-NA•TREN is the only dual-action kit (Oral Probiotic Supplement and Vaginal Homeopathic Treatment with a National Drug Code) available today. 

GY-NA•TREN, the first ever multi-level approach is an innovative formulation for complete vaginal health.
Each kit comes with two bottles of 14 capsules each for a dual-action approach to vaginal health. 

Vaginal Homeopathic Treatment provides 7 active anti-fungalingredients formulated to provide temporary relief of symptoms associated with vaginal yeast overgrowth.^ Oral Probiotic Supplement provides Lactobacillus acidophilus NAS super strain, 5 billion cfu for optimal vaginal and urinary health.* A dual-action approach to relieving symptoms at the source and replenishing the microflora natural to every woman’s body for continued vaginal health.

Vaginal Homeopathic Treatment

• Homeopathic treatments have been used for over 200 years as natural remedies for the human body
• These “remedies” stimulate the human body’s internal mechanism to initiate the healing process
• Our homeopathic treatment is listed with a national drug code (NDC# 32267-930-14)
• Formulated by a medical and homeopathic doctor specifically for women’s vaginal health needs

   

Oral Probiotic Supplement
• Promotes vaginal and urinary tract health*
• Supports immune and digestive function*
• Boosts the body’s natural defenses*
• Produces B vitamins*
• Produces hydrogen peroxide, essential to vaginal health*

   

Please fully read directions and warnings on the GY-NA•TREN box prior to use

NDC # 32267-930-14 (per the manufacturer this is sold as a 2 pack)

Indications based on Homeopathic Materia Medica for self-limiting conditions. These statements have not been evaluated by the Food and Drug Administration.